In person and virtual process mapping experiences to capture and explore variability in clinical practice: application to genetic referral pathways across seven Australian hospital networks.

Focus-group research Implementation science Lynch syndrome Process mapping Qualitative research

Journal

Translational behavioral medicine
ISSN: 1613-9860
Titre abrégé: Transl Behav Med
Pays: England
ID NLM: 101554668

Informations de publication

Date de publication:
11 08 2023
Historique:
medline: 14 8 2023
pubmed: 11 4 2023
entrez: 10 4 2023
Statut: ppublish

Résumé

Genetic referral for Lynch syndrome (LS) exemplifies complex clinical pathways. Identifying target behaviours (TBs) for change and associated barriers requires structured group consultation activities with busy clinicians - consolidating implementation activities whilst retaining rigour is crucial. This study aimed to: i) use process mapping to gain in-depth understandings of site-specific LS testing and referral practices in Australian hospitals and support identification of TBs for change, ii) explore if barriers to identified TBs could be identified through process mapping focus-group data, and iii) demonstrate pandemic-induced transition from in-person to virtual group interactive process mapping methods. LS clinical stakeholders attended interactive in-person or virtual focus groups to develop site-specific "process maps" visually representing referral pathways. Content analysis of transcriptions informed site-specific process maps, then clinical audit data was compared to highlight TBs for change. TBs were reviewed in follow-up focus groups. Secondary thematic analysis explored barriers to identified TBs, coded against the Theoretical Domains Framework (TDF). The transition from in-person to pandemic-induced virtual group interactive process mapping methods was documented. Process mapping highlighted six key areas of clinical practice variation across sites and site-specific TBs for change were identified. Key barriers to identified TBs emerged, categorised to seven TDF domains. Process mapping revealed variations in clinical practices surrounding LS referral between sites. Incorporating qualitative perspectives enhances process mapping by facilitating identification of TBs for change and barriers, providing a pathway to developing targeted interventions. Virtual process mapping activities produced detailed data and enabled comprehensive map development. To achieve change in the health system using implementation approaches, time-poor clinicians must engage in information-gathering and idea-generation activities. This research revealed that qualitative process mapping focus groups held both in-person and virtually can be used to streamline these activities, by simultaneously identifying target behaviours for change, and barriers to change, while gaining information about site-specific clinical processes. Hospital process mapping shows that complex clinical processes vary significantly between sites, and that understanding local variation is crucial to developing targeted interventions. This study has informed new approaches to implementation research methods.

Autres résumés

Type: plain-language-summary (eng)
To achieve change in the health system using implementation approaches, time-poor clinicians must engage in information-gathering and idea-generation activities. This research revealed that qualitative process mapping focus groups held both in-person and virtually can be used to streamline these activities, by simultaneously identifying target behaviours for change, and barriers to change, while gaining information about site-specific clinical processes. Hospital process mapping shows that complex clinical processes vary significantly between sites, and that understanding local variation is crucial to developing targeted interventions. This study has informed new approaches to implementation research methods.

Identifiants

pubmed: 37036763
pii: 7111785
doi: 10.1093/tbm/ibad009
pmc: PMC10415733
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

561-570

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Society of Behavioral Medicine.

Références

J Adv Nurs. 2008 Apr;62(1):107-15
pubmed: 18352969
Asia Pac J Clin Oncol. 2018 Dec;14(6):417-425
pubmed: 30294856
J Clin Oncol. 2013 Apr 1;31(10):1336-40
pubmed: 23401454
Transl Behav Med. 2022 Jan 18;12(1):
pubmed: 34255088
BMJ Open. 2020 Jun 15;10(6):e033552
pubmed: 32540886
Implement Sci. 2013 Oct 16;8:123
pubmed: 24131864
ANZ J Surg. 2019 Oct;89(10):1281-1285
pubmed: 30856687
N Engl J Med. 2006 Jan 19;354(3):261-9
pubmed: 16421367
Gastroenterology. 2000 May;118(5):829-34
pubmed: 10784581
BMC Health Serv Res. 2019 Mar 20;19(1):180
pubmed: 30894169
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
Anesth Analg. 2007 Jan;104(1):140-6
pubmed: 17179259
Implement Sci. 2012 Apr 24;7:37
pubmed: 22530986
Cancer Med. 2017 Jun;6(6):1465-1472
pubmed: 28470797
J Healthc Qual. 2019 Mar/Apr;41(2):110-117
pubmed: 30664034
Med J Aust. 2020 Jun;212(10):459-462
pubmed: 32237278
Br J Surg. 2013 Dec;100(13):1719-31
pubmed: 24227356
Am J Med Qual. 2020 Jul/Aug;35(4):330-340
pubmed: 31581794
BMC Health Serv Res. 2018 Nov 28;18(1):904
pubmed: 30486812
BMC Health Serv Res. 2021 Apr 14;21(1):342
pubmed: 33853610
BMC Health Serv Res. 2016 Mar 12;16:89
pubmed: 26969429
Implement Sci. 2019 Feb 1;14(1):11
pubmed: 30709368
Implement Sci Commun. 2020 Nov 25;1(1):105
pubmed: 33292818
Gut. 2017 Mar;66(3):464-472
pubmed: 26657901
Qual Saf Health Care. 2010 Dec;19(6):e29
pubmed: 21127091
Trials. 2019 Jun 20;20(1):373
pubmed: 31221211
Genet Med. 2013 Dec;15(12):933-40
pubmed: 23639899
J Multidiscip Healthc. 2015 Mar 18;8:139-46
pubmed: 25834455
Gynecol Oncol. 2015 Jul;138(1):109-14
pubmed: 25933682
Fam Cancer. 2008;7(1):41-52
pubmed: 17636426
Genet Med. 2010 Feb;12(2):93-104
pubmed: 20084010
Hered Cancer Clin Pract. 2022 May 4;20(1):18
pubmed: 35509103
Lancet. 2011 Dec 17;378(9809):2081-7
pubmed: 22036019
BMC Health Serv Res. 2010 Jan 07;10:7
pubmed: 20056005

Auteurs

April Morrow (A)

Implementation to Impact Hub, School of Population Health, Faculty of Medicine, UNSW, Sydney, NSW, Australia.

Julia Steinberg (J)

The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, New South Wales, Australia.

Priscilla Chan (P)

Implementation to Impact Hub, School of Population Health, Faculty of Medicine, UNSW, Sydney, NSW, Australia.

Gabriella Tiernan (G)

Implementation to Impact Hub, School of Population Health, Faculty of Medicine, UNSW, Sydney, NSW, Australia.

Elizabeth Kennedy (E)

The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, New South Wales, Australia.

Natasha Egoroff (N)

School of Medicine and Public Health, University of Newcastle, Callaghan, Australia.

Desiree Hilton (D)

Familial Cancer Service, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, NSW, Australia.

Lucien Sankey (L)

Monash Health, Melbourne, Victoria, Australia.

Rebecca Venchiarutti (R)

Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Camperdown, NSW, Australia.

Anne Hayward (A)

The Royal Melbourne Hospital, Melbourne, Victoria, Australia.

Amy Pearn (A)

The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, New South Wales, Australia.

Skye McKay (S)

Implementation to Impact Hub, School of Population Health, Faculty of Medicine, UNSW, Sydney, NSW, Australia.

Deborah Debono (D)

Centre for Health Services Management, School of Public Health, University of Technology Sydney, New South Wales, Australia.

Emily Hogden (E)

Implementation to Impact Hub, School of Population Health, Faculty of Medicine, UNSW, Sydney, NSW, Australia.

Natalie Taylor (N)

Implementation to Impact Hub, School of Population Health, Faculty of Medicine, UNSW, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH